FIRDAPSE Trademark

Trademark Overview

On Friday, October 4, 2013, a trademark application was filed for FIRDAPSE with the United States Patent and Trademark Office. The USPTO has given the FIRDAPSE trademark a serial number of 86082826. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, April 22, 2021. The FIRDAPSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, neurological, muscular, neuromuscular and cancer-associated diseases and disorders
firdapse

General Information

Serial Number86082826
Word MarkFIRDAPSE
Filing DateFriday, October 4, 2013
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, April 22, 2021
Registration Number4700764
Registration DateTuesday, March 10, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 25, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, neurological, muscular, neuromuscular and cancer-associated diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 11, 2013
Primary Code005
First Use Anywhere DateTuesday, January 20, 2015
First Use In Commerce DateTuesday, January 20, 2015

Trademark Owner History

NOT AVAILABLE

Trademark Events

Event DateEvent Description
Sunday, March 10, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, April 22, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, April 22, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, April 22, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, January 27, 2021TEAS SECTION 8 RECEIVED
Wednesday, May 6, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 18, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 10, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 10, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, February 3, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 2, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 29, 2015STATEMENT OF USE PROCESSING COMPLETE
Monday, January 26, 2015USE AMENDMENT FILED
Monday, January 26, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, January 13, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 12, 2015SOU EXTENSION 1 GRANTED
Monday, November 17, 2014SOU EXTENSION 1 FILED
Monday, January 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 17, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, November 18, 2014FAX RECEIVED
Tuesday, May 20, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 12, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 25, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 25, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 5, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 5, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 13, 2014ASSIGNED TO LIE
Friday, January 24, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 24, 2014EXAMINER'S AMENDMENT ENTERED
Friday, January 24, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 24, 2014EXAMINERS AMENDMENT E-MAILED
Friday, January 24, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, January 20, 2014ASSIGNED TO EXAMINER
Friday, October 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 8, 2013NEW APPLICATION ENTERED

Related Keywords

firdapse cancer associated diseases disorders neuromuscular muscular preparations treatment autoimmune neurological